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Abstract
Introduction Children with inherited metabolic diseases
(IMDs) often have complex and intensive healthcare
needs and their families face challenges in receiving
high-quality, family centred health services. Improvement
in care requires complex interventions involving multiple
components and stakeholders, customised to specific care
contexts. This study aims to comprehensively understand
the healthcare experiences of children with IMDs and their
families across Canada.
Methods and analysis A two-stage explanatory
sequential mixed methods design will be used. Stage 1:
quantitative data on healthcare networks and encounter
experiences will be collected from 100 parent/guardians
through a care map, 2 baseline questionnaires and 17
weekly diaries over 5–7 months. Care networks will be
analysed using social network analysis. Relationships
between demographic or clinical variables and ratings of
healthcare experiences across a range of family centred
care dimensions will be analysed using generalised
linear regression. Other quantitative data related to
family experiences and healthcare experiences will be
summarised descriptively. Ongoing analysis of quantitative
data and purposive, maximum variation sampling will
inform sample selection for stage 2: a subset of stage 1
participants will participate in one-on-one videoconference
interviews to elaborate on the quantitative data regarding
care networks and healthcare experiences. Interview data
will be analysed thematically. Qualitative and quantitative
data will be merged during analysis to arrive at an
enhanced understanding of care experiences. Quantitative
and qualitative data will be combined and presented
narratively using a weaving approach (jointly on a theme-
by-theme basis) and visually in a side-by-side joint display.

Strengths and limitations of this study
►► This study will ascertain family perspectives on

healthcare networks and positive and negative care
experiences for children with high care needs, such
as those with inherited metabolic disease, forming
a comprehensive understanding of current care, including gaps in family centred care that will form the
foundation for successful development of complex
interventions to improve healthcare experiences for
this understudied population.
►► We expect this study to contribute to the methodological literature on assessment of healthcare experiences by using a novel combination of approaches,
including care maps, diaries and interviews.
►► This study exemplifies partnership with patients and
their families in co-designing research towards improved healthcare.
►► A limitation of this study is the requirement of
English proficiency for study participation, which
will exclude a potentially more vulnerable population
of children and families who, for example, require
language supports for their healthcare.

Ethics and dissemination The study protocol and
procedures were approved by the Children’s Hospital of
Eastern Ontario’s Research Ethics Board, the University
of Ottawa Research Ethics Board and the research ethics
boards of each participating study centre. Findings will
be published in peer-reviewed journals and presented at
scientific conferences.
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‘phase I’, the first study in our research programme, in
which we seek to build on our previous qualitative studies
to more fully understand and describe the ‘problem’26 27 33:
the nature, frequency, heterogeneity and impact of positive and negative healthcare experiences of children with
IMDs and their families. Such a purpose requires both
quantitative data that can be generalised to a larger population and qualitative data to understand the nuances of
individual experiences and is thus well-suited to a mixed
methods design.34 Mixed methods designs have been
used in several studies of patient or family experiences in
paediatric healthcare.35–41
Objectives
The overall aim of this study is to comprehensively understand the healthcare experiences of children with IMDs
and their families across Canada.
Quantitative objectives
To identify and describe the providers and services
included in children’s care networks and how they
are connected to both the family and to one another,
from parents’ perspectives.
►► To prospectively measure the frequency, heterogeneity and satisfaction with healthcare encounters of
children and their families.
►► To identify the family characteristics and circumstances that form the context in which families experience healthcare, and their association with healthcare
encounter satisfaction.
►►

Qualitative objectives
To explain and enhance our understanding of:
a. parents’ perceptions and assessments of their children’s care networks;
b. how families experience positive and negative
healthcare encounters.

►►

Mixed methods objectives
To merge the quantitative and qualitative findings to
arrive at an enhanced understanding of:
►► the nature of children’s care networks and how they
are experienced and assessed by parents;
►► the family centred elements and processes related to
parent perceptions of positive and negative healthcare encounters.
Pursuit of these objectives will be foundational to
understanding how to develop complex, family centred
care interventions. For example, identifying the constellation of providers and services and their roles and connections in children’s care networks may enable us to identify
key providers for healthcare coordination interventions
(quant, qual). Knowing the most frequently used services
will help with the prioritisation of intervention development and implementation (quant). Understanding
which aspects of care contribute to negative and positive
experiences will help inform the creation of responsive
interventions (quant, qual). An understanding of family
characteristics and situations will shape interventions that
Chow AJ, et al. BMJ Open 2022;12:e055664. doi:10.1136/bmjopen-2021-055664
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Background
Inherited metabolic diseases (IMDs) are individually rare
genetic conditions, often diagnosed in early childhood,
that have a collective estimated global prevalence of 50.9
in 100 000 live births.1 Many children with IMDs have
complex and intensive healthcare needs.2 3 Due in part
to health service inequities related to infrastructure and
funding, they and their families face multiple challenges
in receiving high-quality care4 and, in common with children with medical complexities generally, may not receive
optimal interdisciplinary family centred services.5 6
Patient experience is a key pillar of a high performing
health system.7–9 Assessments of patient experience
frequently address established principles of patient-
centred care,10 including access, coordination, continuity
and communication.8 11 12 In paediatrics, these principles
extend to family centred care, emphasising children’s
developmental needs and recognising the central role
of family members in disease management.13 14 Families
are often experts about the care needs of their children
with rare diseases such as IMDs, underscoring the importance of their perspectives and their engagement in both
healthcare and research.5
Several studies have focused on the quality of life
and caregiving experiences of families of children with
IMDs15–25; a smaller proportion have identified challenges or needs associated with providing and accessing
care.15–19 To begin to understand the healthcare experiences of this potentially underserved population, we
completed two qualitative studies: first with representatives of relevant patient groups, then with caregivers
of children with IMDs enrolled in a Canadian cohort
study.26 27 Overarching themes included a lack of familiarity with IMD care among many care providers outside
of the metabolic clinic and poor suitability of some care
systems to meet the needs of frequent and complex
users. These studies expose a need for interventions that
improve healthcare experiences of children with IMDs
and their families. An Australian study found that families of children with IMDs experienced improved healthcare if care was accessed through a coordinating centre.28
Guidance about family centred care for children with
chronic conditions more generally suggests additional
potential strategies for addressing some of these challenges, for example, co-developed care plans, receipt of
care within a ‘medical home’, relational continuity with a
key provider, improved collaboration between providers
and increased family involvement.5 13 14 29 30 These potential strategies reflect complex interventions: each single
strategy would require multiple interacting components,
targeting multiple individuals or systems and customisation to specific contexts of care, with potential impacts
on a range of outcomes.31 Guided by the UK Medical
Research Council (UKMRC) Complex Interventions
Framework,32 33 we have planned a rigorous, four-phase
research programme (online supplemental material 1) to
develop complex interventions to improve family experiences with care. This protocol outlines our plans for

Open access

Methods
Study design
The UKMRC Complex Interventions Framework, a phased
approach to the design, evaluation and implementation
of complex interventions, guided this study’s design.32 33
Following previous studies of healthcare experiences,42–46
we will also use the Picker Principles of Patient-Centred

Figure 1

Care to provide a framework to guide data collection and
analysis regarding key aspects of family centred care.12
We will conduct a mixed methods study, following a two-
stage explanatory sequential design (figure 1).34 Stage 1:
quantitative data will be collected on parent perceptions
of children’s healthcare networks (the people involved in
a child’s healthcare and how they are connected) and on
healthcare encounters (frequency, context, experiences
with care). These data will be analysed on an ongoing
basis to inform the sample selection for stage 2: two subsets
of participants from stage 1 will participate in qualitative
data collection (interviews) about (i) the participant’s
perception of the child’s care network and/or (ii) the
factors that contributed to a strongly positive or negative
healthcare experience. At the individual level data collection will be sequential: the quantitative collection of data
related to the child’s care network and experiences will
precede the qualitative collection of data related to the
network or to a specific healthcare experience. Data from
both stages will be integrated during analysis. We will

Study design overview: mixed methods explanatory sequential design.
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account for the challenges and realities faced by families
managing their child’s care at home (quant).
The COVID-
19 pandemic has exacerbated existing
challenges related to access to care, and is expected to
continue to affect how healthcare is delivered in the future.
Therefore, we will collect data to understand the current
context of healthcare delivery across Canada during the
pandemic. In particular, we will aim to understand family
experiences with virtual care, since this delivery modality
has become more common due to pandemic response
measures and the increase in its use is likely to influence
healthcare delivery in a postpandemic environment.

Open access

Patient and public involvement
The interventions informed by this study will be complex,
involving diverse systems, providers and families, and aim
to be family centred. This underscores a need to engage
families and providers,48 49 especially in the context of rare
disease where families become experts in their children’s
care needs.50 Parents of children with IMDs and adults
living with IMDs are engaged in this study to provide
expertise on the family/patient experience. Three
family/patient partners (IJ, NP, MS) are study co-investigators, leading the family engagement strategy, advising
and providing expertise, and sharing in decision-making
at all study stages, from conceptualisation to dissemination. The study also engaged 11 patient/family advisors,
recruited through IMD family advocacy and support
organisations, to provide advice and feedback during
study instrument development; 6 of them also pilot tested
the data collection instruments.
Quantitative sample
Participants will be parents or legal guardians (‘parents’)
of children diagnosed with an IMD. Although children’s
self-report of experiences is important, we seek to understand the experiences of healthcare for younger children (≤12 years). Parents are the family members most
actively involved in seeking and managing healthcare for
their children and thus are likely the best informants to
provide comprehensive information on healthcare for
this age group. For each participating family, one parent
will be identified by the family as the ‘designated parent’
to provide data regarding one child in their family with
an IMD (‘designated child’).
Eligibility criteria are described in table 1. Child age
will be restricted to ≤12 years as adolescents with chronic
conditions have different healthcare and clinical treatment needs.51 52 With respect to eligibility of IMD diagnoses, >1000 IMDs have been identified.53 IMDs typically
follow one of three broad clinical course trajectories, with
different implications for healthcare usage and experiences: (a) chronic and generally non-progressive; (b)
acute episodes of severe illness with or without accompanying chronic multisystem sequelae and (c) progressive multisystem disease. Children with any of 30 priority
IMDs included in an existing Canadian paediatric
cohort study that will serve as one potential recruitment
source54 55 are eligible for this study (table 1). Few of the
IMDs included in that cohort study, however, are characterised as following trajectory (c). Thus, children will also
be eligible for this study if they have an IMD that meets
clinical criteria associated with trajectory (c) (table 1), to
be evaluated by clinician investigators on a case-by-case
basis.
In order to collect data on healthcare experiences
from a diverse sample of families, we will use a purposive,
4

maximum variation sampling approach56–58 to identify
and recruit participants. We will aim for maximum variation on six selection variables on which experiences with
care are anticipated to vary: study centre, travel time from
home to study centre, child’s sex, child’s age (years), IMD
type and IMD typical clinical course trajectory. Treatment
protocols and healthcare service availability and practice
vary by IMD, clinical course classification, study centre
and/or distance to specialists.27 59 Healthcare encounters
tend to be more frequent in the first years following an
IMD diagnosis (usually in infancy) and parents characterise this time as uncertain and stressful.27 Sex differences can affect metabolism, resulting in different care
experiences for girls and boys.60 61 We will prioritise the
selection of participants who expect the designated child
to have ≥1 healthcare encounter per month during the
study to collect sufficient data for analysis.
Quantitative procedures
Participants will be recruited from the existing cohort
study and/or from the study centres across Canada.
Eligible parents will be notified of the study by the study
team (by telephone) or by their associated study centre
(by telephone or at a clinic visit). For those notified by
telephone, up to three contact attempts will be made.
Participants will be enrolled on a rolling basis and the
sample continually assessed for diversity on study selection variables to identify characteristics desired for
further recruitment. Based on our previous experiences conducting studies with this population, we estimate a 50% response rate. Recruitment commenced in
November 2020 and will be concluded when 100 families
are enrolled. Interested parents will receive via email a
postcard with study information and a link to the online
Eligibility and Pre-Screening Questionnaire (5–10 min).
Data collection procedures are outlined in figure 1.
All questionnaires will be web-based. Study data will be
collected and managed using Research Electronic Data
Capture hosted at the Children’s Hospital of Eastern
Ontario (CHEO).62 63 The participant, if they desire, may
consult other family members, including the designated
child, to complete the data collection tools. Children
will continue to access healthcare normally. Participants
will be reminded up to two times to complete each
questionnaire.
Quantitative data elements and instruments
Data collection instruments are described in table 2.
Care map instructions, sample survey questions and
measurements and interview guides are provided in
online supplemental material 3. Instruments were
developed with input from clinicians, methodological
experts and family/patient partners and advisors and
pilot tested.
Care maps
In this study, a ‘care map’ is a pictorial representation of
the networks of healthcare providers around a child with
Chow AJ, et al. BMJ Open 2022;12:e055664. doi:10.1136/bmjopen-2021-055664
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use the STrengthening the Reporting of OBservational
studies in Epidemiology guideline47 to report the study
(online supplemental material 2).

Open access

Inclusion

Exclusion

►► The designated parent and designated child are Canadian residents
►► The designated child is ≤12 years at prescreening
►► The designated child is receiving healthcare from one of 11 participating

Designated parents who cannot speak,
write and read English comfortably

paediatric metabolic clinics across Canada: Alberta’s Children Hospital, British
Columbia Children’s Hospital, Children’s Hospital of Eastern Ontario, Health
Sciences Centre Winnipeg Children’s Hospital, The Hospital for Sick Children,
IWK Health Centre, Kingston General Hospital, London Health Sciences Centre,
McMaster Children’s Hospital, Montreal Children’s Hospital, Stollery Children’s
Hospital
►► The designated child has an IMD that is either
1. identified in the following list (these conditions were the focus of an existing
cohort study; most have a typical clinical course that aligns with what we call
trajectory a or trajectory b):
–– β-Ketothiolase deficiency
–– Arginase deficiency
–– Argininosuccinic aciduria
–– Carbamoyl phosphate synthetase deficiency
–– Carnitine uptake defect
–– Citrin deficiency
–– Citrullinemia
–– Farber disease
–– Galactosemia
–– Glycogen storage disease type 1
–– Glutaric acidemia type I
–– Guanidinoacetate methyltransferase deficiency
–– HMG-CoA lyase deficiency
–– Homocystinuria
–– Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
–– Isovaleric acidemia
–– Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
–– Maple syrup urine disease
–– Medium chain acyl-CoA dehydrogenase deficiency
–– Methylmalonic acidemias
–– Mucopolysaccharidosis type I
–– Multiple carboxylase/biotinidase deficiency
–– N-acetylglutamate synthetase deficiency
–– Ornithine transcarbamylase deficiency
–– Phenylalanine hydroxylase deficiency
–– Propionic acidemia
–– Pyridoxine-dependent epilepsy
–– Trifunctional protein deficiency
–– Tyrosinemia type I
–– Very long-chain acyl-CoA dehydrogenase deficiency
2. or meets the following clinical criteria (included to expand the list of eligible
conditions and to increase representation of IMDs with a typical clinical course
that aligns with what call trajectory c):
–– involves at least three organ systems and
–– chronic complications of the disease get progressively worse over time,
even with available treatment
HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A; IMD, inherited metabolic disease.

an IMD and their family, commonly used in research on
children with complex or chronic health conditions.5 64–66
Guided by a set of instructions,67 care maps will be drawn
by hand, photographed and uploaded to the study data
collection database by the participant, and a digital
version rendered by the study team.
Chow AJ, et al. BMJ Open 2022;12:e055664. doi:10.1136/bmjopen-2021-055664

Baseline questionnaires
Participants will be invited to complete three questionnaires: the Care Map Questionnaire, the Baseline Questionnaire and the Pre-Questionnaire for the Weekly Logs
(content overview, table 2). The Baseline Questionnaire
includes a number of validated instruments. Child health
5
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Data collection
period
Data instrument

Data type

Baseline

 

 Care map

Quantitative

40

 Care Map
Questionnaire

Quantitative

5

 Baseline
Questionnaire

Quantitative

20–40

 Pre-Questionnaire Quantitative
for the Weekly Logs

5–20

Data will be used to tailor the healthcare diaries, to reduce repetition of
questions where responses are anticipated to remain constant over the study
period.

5–60

Descriptive data on healthcare encounters including: the mode of interaction,
the care setting if applicable, the healthcare providers involved, the date of the
encounter, financial costs, time inputs and any parent-perceived effects of the
COVID-19 pandemic (eg, on scheduling or delivery of care).
Optional, open-ended questions for descriptions of participant perceptions of
care in each Picker Principle domain, and for the overall encounter.
The Experience Questionnaire will be tailored to each encounter’s mode of
interaction (in-person or virtual/remote), care setting and context (planned or
urgent care; whether it is a ‘frequent’ care encounter, as identified on the Pre-
Questionnaire for the Weekly Logs).

Follow-up

Instrument and data details
Participant creation of a care map of their perceptions regarding their child’s
network of care providers, which providers are perceived to work together to
coordinate their child’s care, and which providers are considered ‘key providers’
(maximum 10).
Participant perceptions about:
►► Coordination of their child’s care.
►► Familiarity with their child by identified key healthcare providers.

Demographics and potential predictors of healthcare encounter satisfaction
ratings, for example, child health status, child and family characteristics, family
resources in IMD management and effects of the COVID-19 pandemic on child
health and healthcare since March 2020.

 

 Healthcare diaries† Quantitative,
qualitative

 Interviews

Instrument
completion
time* (min)

Qualitative

(a) 30–60
(b) 30–45

(a) Map interviews: seek to understand and elaborate on the care map,
including how the participant selected providers to include on the map, the
roles and relationships with the family for the providers designated on the map
as ‘key providers’, the meaning of connections drawn between providers and
how the participant feels about the effectiveness of the care network, including
what improvements they see as potentially important.
(b) Encounter interviews: seek to clarify, interpret and deepen our
understanding of information collected in the healthcare diaries, specifically:
elements of a healthcare encounter that contributed to participants’ high or low
satisfaction with that encounter; the impact of these experiences, especially
the challenges, on the child, parent, other family members and the context of
general healthcare for their child (ie, comparison between this encounter and
past similar encounters). Impact will be iteratively defined, depending on the
information shared by participants, and may include psychosocial, health and/
or economic impacts.

*Estimated.
†All elements are completed once except the healthcare diaries, which are completed weekly ×17 weeks.

status will be assessed using the Child Health Questionnaire - Parent Form 5068 for children ≥5 years or the Infant
and Toddler Quality of Life Questionnaire-47-item short-
form69 for children <5 years. Both are parent-reported
measures and have good validity and reliability.69–71
Parent-perceived quality of life related to caring for the
designated child will be measured using the CarerQol
instrument. The CarerQol has good psychometric properties72–75 and has been used with parents of children with
chronic conditions, including rare diseases.76–79 We reformatted the measure for online use.
6

Healthcare diaries
The Healthcare Diary (‘Diary’) is composed of two parts:
a Healthcare Log and Experience Questionnaire. Once
per week, participants will record whether a child had
any healthcare encounters in a given week on the Healthcare Log. If yes, they will complete an Experience Questionnaire for each of those encounters. Diary methods
have been used in health studies to capture real-time
information to reduce the recall errors associated with
retrospective surveys,80 81 with electronic diaries yielding
higher quality data than paper diaries.82 83 The definition
Chow AJ, et al. BMJ Open 2022;12:e055664. doi:10.1136/bmjopen-2021-055664
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Table 2 Data collection instruments
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Healthcare encounter definitions/eligibility.

of a healthcare encounter is provided in figure 2. Evaluations will be made for the overall experience as well as
in eight domains consistent with the Picker Principles of
Patient-Centred Care where applicable84: access to care,
information sharing/communication, care coordination,
physical comfort, emotional support, family involvement,
respect for the patient/family and continuity/follow-up.
The Consumer Assessment of Healthcare Providers and
Systems Child Hospital Survey,85 Ontario Emergency
Department Patient Experience of Care Survey,86 Outpatient Survey (Christine Kouri, Manager for Patient Experience, CHEO, email communication, October 2017) and
the Cost Utilisation Survey for Child Phenylketonuria87
were used as resources for our diary instrument development; diary questions were either author-developed,
informed by or adapted from these resources.
We will collect prospective data on blood draws done
at home by the family, following the same family centred
care domains. For many IMDs, blood draws are essential
to the ongoing monitoring of a child’s health status, and
Chow AJ, et al. BMJ Open 2022;12:e055664. doi:10.1136/bmjopen-2021-055664

although sometimes conducted by the family, require an
ongoing dialogue with healthcare providers to adjust a
child’s medication, diet or other treatment.
Qualitative sample
The two qualitative samples will be nested in the quantitative sample. Qualitative participants queried about their
children’s care networks must have completed the Care
Map Questionnaire, and those queried about their positive or negative encounters must have completed at least
four diaries. For the interview focused on the healthcare
encounter (‘encounter interview’), we will select participants who have had a healthcare encounter with which
they reported they were ‘extremely satisfied’, ‘extremely
dissatisfied’ or ‘somewhat dissatisfied’ overall or on at
least one family centred care domain. We will use purposive, maximum variation sampling and extreme case
sampling to separately sample participants for each interview set,56–58 aiming for sample variation across the selection variables used for the quantitative sample and across
7
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Qualitative procedures and data elements
On a rolling basis, participants will be identified and
invited by email to participate in a one-
on-
one, semi-
structured interview held by videoconference or by audioconference, according to participant preference. For the
interview focused on care network (‘map interviews’),
participants may be sampled at any time after completing
the Care Map Questionnaire. For the encounter interviews, participants will be sampled during and up to
3 weeks after completing week 17 of the diaries. Interviews will be audio-recorded with participant consent and
transcribed. Up to three attempts to contact participants
will be made to invite interview participation. Both interview sets will be semi-structured and informed by an interview guide.
Sample size
While we did not conduct a formal power calculation
for the quantitative part of this study, given our largely
descriptive purpose, we deemed a sample size of 100 families sufficiently large to support planned analyses across a
heterogeneous sample, while maintaining feasibility for
recruitment and study administration.
Because of the duration and intensity of study participation, we anticipate some dropout. Dropout rates
may increase with longer study lengths.88 89 To facilitate
participant retention, we pilot tested the feasibility of
study questionnaires. In addition, we will: (1) enrol a new
participant to replace any participant withdrawn before
completion of at least four diaries; (2) actively monitor
completion of study instruments and follow-up with participants if necessary; (3) provide participants with financial
compensation (up to CA$400 in gift cards) for their time
and as a participation incentive90; (4) encourage the
scheduling of time each week to complete the diaries; (5)
allow for instrument completion over multiple sittings
and (6) allow for flexibility of instrument completion.
A participant will be considered lost to follow-up on
notification of withdrawal or non-completion of an instrument within prespecified timeframes; they will have the
option to continue in the study if they proactively express
a desire to do so. Data collected up to time of withdrawal
will be included in the study.
The qualitative sample sizes will not be determined in
advance; they will be assessed continuously and finalised
during data collection. Information power is a methodological model for determining a qualitative sample size,
and has five contributing dimensions related to: narrow
versus broad qualitative objectives; the homogeneity of
the sample on important characteristics; use of a theoretical framework; quality of interview data and planned
8

analytic strategy (case vs cross-case analysis).91 Based on
this concept and previous qualitative studies with parents
of children with chronic conditions,26 92–94 we anticipate a
sample size of approximately 15–30 participants for each
interview set.
Analyses
Quantitative analyses
We will describe continuous variables using means and
SD or medians and IQRs, and categorical variables using
counts and proportions (%). Baseline data will be analysed to describe the characteristics of participating families, including child and parent demographic variables,
quality of life, experiences with managing an IMD in the
context of COVID-19 and experiences with managing an
IMD in general, including time and cost impacts.
From the care maps, children’s networks of care
providers and their interactions will be analysed using an
adapted form of social network analysis,95 96 conducted
using UCINET software.97 We will describe who is in the
network (nodes), identify the most common providers
perceived as key providers and analyse connections
among providers from parents’ perspectives (social
network analysis calculations of network size and density
and the degree centrality of providers).
From the diaries, we will calculate the frequency (count
and rate) of encounters by participant/child, accounting
for follow-up time contributed. We will calculate counts
and proportions to describe characteristics of healthcare
encounters (eg, preplanned vs unplanned, the types of
healthcare providers interacted with, care setting or
mode of interaction), overall satisfaction ratings and
satisfaction ratings by Picker Principles (access to care,
communication, coordination of care, etc).
To explore the potential relationships between a range
of explanatory variables and satisfaction with healthcare
experiences, depending on data quantity and distribution, we propose to use generalised linear regression analysis. The unit of analysis will be the individual healthcare
encounter with each child having potentially different
numbers of encounters. Explanatory variables will include
both time-fixed and time-varying factors, namely child,
family and setting/provider characteristics (eg, child age,
IMD clinical course trajectory, travel time from home to
care setting, socioeconomic status), healthcare setting
and mode of interaction. The five-point ordinal score for
the overall experience of the healthcare encounter will
be analysed using ordinal logistic regression. Correlation
in repeated measures on the same child will be accommodated either by directly modelling the covariance matrix
or through the addition of child-specific random effects.
A similar approach will be used to analyse the experience
ratings within the eight family centred care domains.
This study will minimise missing data by regularly
monitoring completion of instruments and diary entries
and following up with participants as necessary. Participants will have access to ongoing support from the study
team. We will report on the number of missing values for
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healthcare settings in the encounter interviews. For the
encounter interviews, if the parent who accompanied the
child to the encounter is not the designated parent, they
will be invited but asked to provide informed consent
before proceeding. Some participants in the quantitative
sample may be invited to participate in both interviews.

Open access

Qualitative analyses
Guided by principles of family centred care and incorporating an inductive approach, we will use thematic analysis98 to guide the coding and analysis of qualitative data
across participants, using the following recommended
process: (1) review the interview transcripts and familiarise themselves with the data; (2) do an initial, systematic coding of the data; (3) identify themes of codes;
(4) review the generated themes against both the initial
codes and the original data; (5) refine the themes and (6)
select and review extracts to illustrate the themes. We will
repeatedly cycle through steps, particularly steps 3–4, to
ensure the themes remain reflective of the original data.98
Mixed methods integration and analysis
The two types of data will be integrated at several points in
the study. The quantitative data will be used to inform the
qualitative sample as well as the interview questions and
topics. We will compare the qualitative sample with the
quantitative sample on the quantitative sampling selection variables. The quantitative and qualitative results
will be merged in analysis and integrated to better understand the elements and processes related to healthcare
networks and to positive or adverse healthcare encounters than would be gained from either data type alone.34
In the final report, the qualitative and quantitative results
will be integrated narratively using a weaving approach99
(reported together, grouped by theme or concept) and
presented visually in a side-by-side joint display with interpretations of the combined results and inferences about
the meaning of the integrated data.100

Discussion
This study will collect important information about
parent perceptions about their families’ experiences with
healthcare for children with IMDs, a population with
complex needs. Few paediatric studies have attempted
to collect similarly comprehensive data on healthcare
experiences.40 Previous studies of children with IMDs and
their families have focused on the impact of the IMD on
the child, caregiver or family well-being16–22 25 and/or on
family experiences managing healthcare.15 23 25 To our
knowledge, this is the first broad study of healthcare experiences in paediatric IMDs. We have designed a study that
draws on mixed methods that best suit the research objectives, enabling the collection of experiential information
Chow AJ, et al. BMJ Open 2022;12:e055664. doi:10.1136/bmjopen-2021-055664

of both breadth and depth. Diaries are an innovative tool
in health research with potential for collecting real-time
quantitative and qualitative data simultaneously. Care
maps provide useful insight on how participants conceive
of the networks of care around their children.
The main findings of this study will inform future phases
of our research programme, culminating in the co-development of family centred interventions to improve
healthcare for children with IMDs and their families.
Comprehensive, prospective information collected on
individual healthcare experiences will help elucidate
the elements of healthcare that contribute to caregivers’
negative and positive experiences. This information will
also enable an assessment of the degree to which healthcare experiences are family centred, ultimately helping to
inform the creation of responsive interventions, especially
for highly frequented services. Care map data will identify
key providers and enable an understanding of how participants perceive providers to be connected to each other
and to the family. This may help to identify key providers
who may be able to lead a child’s ‘medical home’, playing
an active role in coordinating their healthcare. Knowledge about the time, financial costs and other inputs
required to care for a child with an IMD is necessary to
ensure that interventions are responsive to the realities
of families for whom the interventions are designed to
support. Data captured on healthcare experiences during
the COVID-19 pandemic will contribute important information on the benefits and drawbacks of significant
changes to healthcare delivery, such as virtual healthcare,
which can improve the way that this care is delivered in
the future. Through our larger research programme, the
evidence generated in this study will have a direct, actionable impact on family centred healthcare for paediatric
IMDs.
This study has limitations. All study data will be sought
from parents. Their perceptions of their child’s healthcare,
for example, whether or not two providers work together
to coordinate their child’s care, may differ from providers’
perceptions. However, healthcare providers will be interviewed about their perceived barriers to and facilitators
of effective healthcare for children with IMDs in the next
phase of the research programme. Requiring English proficiency for study participation will limit the generalisability
of study findings and will exclude a potentially more vulnerable population of children and families who, for example,
require access to translators and additional supports as part
of their care.
This study may be affected by selection and information
biases. We will prioritise the selection of participants who
expect the designated child to have multiple healthcare
encounters during the study; our quantitative sample will
be over-representative of families who are frequent healthcare users. This characteristic of our anticipated sample
will increase the number of prospective healthcare experiences reported; however, it may limit the generalisability
of quantitative findings. Although Canada has a publicly
funded healthcare system, access to all care and services is
9
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each variable of interest, the reasons for missing values
(if known), characteristics of participants with missing
versus non-missing values for key variables and missing
data counts for each analysis. Our analytic strategy for
managing missing data will depend on the extent of
missingness of data for particular analyses and may rely
on complete case analysis or multiple imputation. Withdrawn participants will be considered lost to follow-up at
the date of their last completed baseline instrument or
Healthcare Diary.

Open access

Ethics and dissemination
The study protocol and procedures were approved by
associated research ethics boards (online supplemental
material 4). Participants will provide informed consent.
Study data will be analysed and stored securely.
Study findings will be published in peer-reviewed, open
access journals and presented at relevant conferences.
Additionally, a summary of study results will be shared
with interested participants (opt-
in). Study results will
also inform future phases of our research to develop
interventions to improve family centred healthcare for
this population.
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not equitable.101 A higher frequency of encounters may indicate greater access to care. Children with fewer expected
encounters will still be enrolled in the study, and access to
care (unavailable services, out-of-pocket expenses) will be
analysed. Past positive or negative experiences with care may
motivate parents to participate in a study that provides the
opportunity to share those problems and experiences. Non-
response bias has been associated with both high and low
patient satisfaction.102 103 Parents whose children are experiencing urgent or critical healthcare issues, whose children
are newly diagnosed (often associated with younger age) or
who experience significant financial and time costs may feel
overwhelmed and be less likely to participate or remain in
the study than parents whose children’s health issues are
relatively stable.26 104 We will attempt to minimise the burden
of study participation by employing web-based data collection and offering compensation for study participation. To
ensure that lack of home internet access is not a barrier to
study participation, participants may be loaned a study tablet
with a mobile data plan to participate in the study. We anticipate that this may affect 10–15 participants.105
Factors such as recall and negativity bias may affect the
reporting of all healthcare encounters. Our collection
of prospective data via diaries, however, aims to capture
experiences during all healthcare encounters, positive
and negative, with a high frequency of reporting to mitigate errors associated with recall time.81 106 The perspectives of the interviewer and data analysts may affect the
collection and analysis of qualitative data. Interviewers
will be trained by investigators with expertise in qualitative interviewing. Interviews will be transcribed as soon as
possible after interviews and reviewed.
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